Featured Post
December 2, 2020
As the Supreme Court mulls yet another challenge to the constitutionality of the Affordable Care Act (ACA), we have new evidence of the law’s positive impact on young adults, who were allowed to stay on their parents’ insurance until age 26 under the Dependent Coverage Provision (DCP). The ACA helped young adults with cancer maintain continuous coverage, which is key to maintaining access to cancer treatment.
In a recent retrospective cohort study, my colleagues and I found that cancer patients who turned 19 in 2010-2012 (who were eligible to stay on their parents’ insurance) were 15% less likely to lose coverage than those who turned 19 in 2007-2009, before the ACA. We used commercial claims data to identify about 2,800 young adults with a cancer diagnosis between 2000 and 2015, and compared them to their peers prior to the ACA’s implementation. We matched the two groups on cancer type, diagnosis date, and clinical characteristics, and compared time to loss of insurance over 5 years.
May 17, 2019
JUUL recently launched a new ad campaign made for adults, which encourages adult smokers to “Make the Switch,” as JUUL was designed with smokers in mind. This is just the latest effort by JUUL to try to convince policymakers, health professionals and anti-smoking advocates that their product is for adults, rather than for the millions of teens across the country who have become addicted to the tobacco device. And yet, new research from Stanford University has confirmed what many have accused the company of doing for years: JUUL intentionally targeted and marketed their products to teens.
May 7, 2019
An important, yet often overlooked aspect of comprehensive health care for a “graying” U.S. population is dental health. In a new commentary, Tim Wang, Mark Wolff, and Neeraj Panchal bring attention to the oral health needs of a growing geriatric population in the U.S., and suggest practical ways to prepare providers to meet the challenge of treating this unique group.
April 26, 2019
At first glance, it appears that the new Veterans Affairs (VA) Center for Innovation for Care and Payment shares much in common with the Center for Medicare and Medicaid Innovation (CMMI). Both are charged with implementing payment and care models that address rising costs, while maintaining or improving quality of care. But Adjunct Senior Fellow Liao and colleagues point out that the new VA Center will (and should) have different priorities, test different models of payment, and target different clinical conditions than those implemented by CMMI.
April 26, 2019
Public reporting of cardiovascular outcomes remains controversial, 20 years after New York became the first state to mandate reporting of mortality data for percutaneous coronary intervention (PCI). It has been associated with a lower likelihood of performing potentially lifesaving procedures, perhaps reflecting an avoidance of intervening in high-risk cases. It’s possible that public reporting may also impact decisions to perform nonreported but related cardiovascular procedures. In a new study, my colleagues and I looked at how public reporting of PCI outcomes influenced the decision to provide out-of-hospital cardiac arrest (OHCA) patients with a coronary angiography.
April 12, 2019
The world of health care is divided into many areas of specialization. Not all of us realize that – in addition to specializing in organ systems or diseases – clinicians can devote their practice to providing general care to patients in a specific setting. A recent illustration of this concept is nursing homes specialists, or ‘SNFists,’ who focus on caring for patients in nursing homes (skilled nursing facilities).
April 5, 2019
[cross-posted from Health Affairs]
Political debate over the Affordable Care Act has defined the health policy political landscape for nearly a decade. The impassioned back and forth over whether to “repeal and replace” or strengthen and defend the law has been a focus of multiple election cycles and millions of dollars in political ad spending. Amidst this ongoing discourse, it is easy to overlook the law’s important reforms to employer-sponsored insurance (ESI), which covers the majority of nonelderly Americans. The escalating costs faced by individuals and families with ESI have received far less attention than costs on the individual market or in public programs, but affordability concerns for this group are no less important.
March 25, 2019
Do residents need more sleep? Two new studies in the New England Journal of Medicine compare the effects of standard versus flexible duty-hours on residents’ sleep and patient safety.
March 14, 2019
A new study in BMJ Open led by LDI Senior Fellow Genevieve Kanter, in collaboration with colleagues Michelle Mello at Stanford, Daniel Carpenter at Harvard, and Lisa Lehmann at the Veterans Health Administration, finds that the Open Payments program has had little success in improving public awareness and knowledge of industry payments.
March 13, 2019
Every day, we hear about the staggering toll of the opioid overdose crisis. Despite effective medications for opioid use disorder, such as buprenorphine and methadone, few people receive treatment. The ongoing challenge is to expand access to these lifesaving treatments to people who need them the most. Emergency departments, which treat patients 24/7 and provide an entry point into the health system, are a promising place to start. With my colleagues Kit Delgado, Austin Kilaru, Jeanmarie Perrone, Zack Meisel, Jessica Hemmons, and Dina Abdel Rahman, I surveyed emergency medicine physicians in two Penn Medicine hospitals to understand the barriers and facilitators to starting buprenorphine in the emergency department.
March 6, 2019
It’s a policy decision with direct life-and-death consequences. Should naloxone, the prescription rescue medication that reverses the effects of an opioid overdose, be sold over the counter? As deaths from opioid overdoses continue to increase, consensus is building on the need to make life-saving naloxone more readily available. The question is, will selling naloxone over the counter (OTC) improve access, even if the out-of-pocket price for consumers goes up because some insurers will no longer cover it?
March 4, 2019
Although the phenomenon of “surprise billing” has become common, no research has examined how consumers respond to surprise bills and alter their health-seeking behavior. In our new study in Health Affairs, we investigate how mothers respond to receiving a surprise medical bill after delivering their first child. Those who received a surprise out-of-network bill for their first delivery had 13% greater odds of switching hospitals for their second delivery compared to those who did not get a surprise bill.
February 25, 2019
After delivering a keynote at the recent Wharton Health Care Business conference, Centers for Medicare and Medicaid Services Administrator (CMS) Seema Verma sat down with a group of LDI Senior Fellows to discuss current federal initiatives, understand relevant research and research gaps, and exchange ideas.